Why TransEnterix Stock Is Rebounding Today
TransEnterix (NYSEMKT: TRX), a small-cap robotic-surgery company, is on the rebound today with its shares up by 21.41% on heavy volume, as of 11:05 a.m. EDT.
Prior to today's double-digit move, TransEnterix's stock had fallen by more than 40% following the FDA approval of its minimally invasive robotic-surgery system, Senhance, earlier this month, which initially sparked the company's shares to rise by more than 200% in a single day.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Stock
€221.05
-0.230%
The stock is an absolute favorite of our community with 57 Buy predictions and no Sell predictions.
With a target price of 228 € there is a slightly positive potential of 3.14% for Johnson & Johnson compared to the current price of 221.05 €.
